Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4380-4. doi: 10.1016/j.bmcl.2009.05.086.

Timothy Coon ¹, Wilna J Moree, Binfeng Li, Jinghua Yu, Said Zamani-Kord, Siobhan Malany, Mark A Santos, Lisa M Hernandez, Robert E Petroski, Aixia Sun, Jenny Wen, Sue Sullivan, Jason Haelewyn, Michael Hedrick, Samuel J Hoare, Margaret J Bradbury, Paul D Crowe, Graham Beaton

Affiliations

Affiliation

1 Neurocrine Biosciences, 12780 El Camino Real, San Diego, CA 92130, USA.

PMID: 19553115 DOI: 10.1016/j.bmcl.2009.05.086

Abstract

The benzimidazole core of the selective non-brain-penetrating H(1)-antihistamine mizolastine was used to identify a series of brain-penetrating H(1)-antihistamines for the potential treatment of insomnia. Using cassette PK studies, brain-penetrating H(1)-antihistamines were identified and in vivo efficacy was demonstrated in a rat EEG/EMG model. Further optimization focused on strategies to attenuate an identified hERG liability, leading to the discovery of 4i with a promising in vitro profile.

Name
Email *

	Sorry, but the email address you supplied was invalid.